Chemours
462 hedge funds and large institutions have $5.42B invested in Chemours in 2017 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 139 increasing their positions, 147 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
462
Holders Change
+4
Holders Change %
+0.87%
% of All Funds
11.54%
Holding in Top 10
6
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-50%
% of All Funds
0.15%
New
70
Increased
139
Reduced
147
Closed
61
Calls
$79.4M
Puts
$64.6M
Net Calls
+$14.8M
Net Calls Change
-$51.8M
Top Buyers
| 1 |
Millennium Management
New York
|
$112M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
$49.8M |
| 3 |
Norges Bank
Oslo,
Norway
|
$312M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
$67.8M |
| 5 |
SCM
Sirios Capital Management
Boston,
Massachusetts
|
$37.4M |
Top Sellers
| 1 |
BlackRock
New York
|
$595M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$36.6M |
| 3 |
GC
Greenlight Capital
New York
|
$137M |
| 4 |
Northern Trust
Chicago,
Illinois
|
$61.2M |
| 5 |
State Street
Boston,
Massachusetts
|
$180M |
